Erratum to “Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome” - Cesar Daniel Alonso-Bello; María del Carmen Jiménez-Martínez; María Eugenia Vargas-Camaño; Sagrario Hierro-Orozco; Mario Alberto Ynga-Durand; Laura Berrón-Ruiz; Julio César Alcántara-Montiel; Leopoldo Santos-Argumedo; Diana Andrea Herrera-Sánchez; Fernando Lozano-Patiño; María Isabel Castrejón-Vázquez (Case Reports in Immunology)